Hundertmark, Moritz JAdler, AmandaAntoniades, CharalambosColeman, RuthGriffin, Julian LHolman, Rury RLamlum, HananLee, JisooMassey, DanielMiller, Jack J J JMilton, Joanne EMonga, ShvetaMózes, Ferenc ENazeer, AreeshaRaman, BettyRider, OliverRodgers, Christopher TValkovič, LadislavWicks, EleanorMahmod, MaslizaNeubauer, Stefan2023-06-132023-06-132023-05-30Hundertmark, M J, Adler, A, Antoniades, C, Coleman, R, Griffin, J L, Holman, R R, Lamlum, H, Lee, J, Massey, D, Miller, J J J J, Milton, J E, Monga, S, Mózes, F E, Nazeer, A, Raman, B, Rider, O, Rodgers, C T, Valkovič, L, Wicks, E, Mahmod, M & Neubauer, S 2023, 'Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin : The Randomized, Controlled EMPA-VISION Trial', Circulation, vol. 147, no. 22, pp. 1654-1669. https://doi.org/10.1161/CIRCULATIONAHA.122.0620210009-7322ORCID: /0000-0003-1336-7744/work/136883008https://hdl.handle.net/2164/20847Acknowledgments The authors express their gratitude toward the Oxford cardiovascular magnetic resonance nursing team, specifically Judith DeLos Santos, Catherine Krasopoulos, Marion Galley, and Claudia Nunes; and the diabetes trials unit team, particularly Irene Kennedy, for her organization skills. The authors also thank the team of the computed tomography suite at the Manor Hospital Oxford as well as all patients who participated in this trial. Drs Holman and Neubauer are Emeritus National Institute for Health Research senior investigators. The views expressed are those of the author(s) and not necessarily those of the National Health Service, National Institute for Health and Care Research, or Department of Health. Sources of Funding Boehringer Ingelheim is the sponsor of the EMPA-VISION study and was involved in early stages of its study design. Boehringer Ingelheim employees (Drs Lee and Massey) also supported preparation of this manuscript. Dr Neubauer acknowledges support from the Oxford British Heart Foundation Centre of Research Excellence. Drs Holman and Neubauer were supported by the Oxford National Institute for Health Research Biomedical Research Centre. Drs Rodgers and Valkovič are funded by Sir Henry Dale Fellowships from the Wellcome Trust and the Royal Society [098436/Z/12/B and 221805/Z/20/Z, respectively]. Dr Valkovič also gratefully acknowledges support of the Slovak Grant Agencies VEGA (Vedecká grantová agentúra) [2/0003/20] and APVV (Slovak Research and Development Agency) [No. 19–0032]. Dr Miller acknowledges support from the Novo Foundation (NNF21OC0068683).151262107engSubstantive connection via an eligible employment contractR MedicineWellcome Trust098436/Z/12/BSupplementary InformationRJournal article10.1161/CIRCULATIONAHA.122.06202114722